Transcription of intermediate filament genes is enhanced in focal cortical dysplasia - PubMed (original) (raw)
Transcription of intermediate filament genes is enhanced in focal cortical dysplasia
J P Taylor et al. Acta Neuropathol. 2001 Aug.
Abstract
Focal cortical dysplasia (FCD) is characterized by disorganized cerebral cortical cytoarchitecture. Increased expression of several intermediate filament (IF) proteins such as neurofilament, vimentin, alpha-internexin, and nestin observed in dysplastic "balloon" neurons (DN) may contribute to disrupted cortical lamination. We hypothesized that increased IF protein expression results from enhanced IF gene transcription within dysplastic neurons. We used a novel strategy to evaluate IF mRNA expression in three FCD specimens from medically intractable epilepsy patients. Poly(A) mRNA was amplified (aRNA) from single microdissected DN, morphologically normal neurons at the margin of the FCD resection, morphologically normal neurons in non-FCD cortex from epilepsy patients, and normal control neurons. Radiolabeled aRNA from single neurons was used to probe cDNA arrays containing the low (NFL), medium (NFM) and high (NFH) molecular weight neurofilament isoform, alpha-internexin, desmin, vimentin, peripherin (PRPH), nestin, and glial fibrillary acidic protein (GFAP) cDNAs. Hybridization intensity of aRNA-cDNA hybrids was used to quantify relative IF abundance. Increased expression of nestin, alpha-internexin, PRPH, vimentin, NFL, NFM, and NFH mRNAs was found in DN when compared with the three control neuronal subtypes. Desmin and GFAP mRNAs were not detected in any cell types. Expression of PRPH mRNA and protein in select DN was confirmed by reverse transcription-polymerase chain reaction and immunohistochemistry. We conclude that aberrant expression of IF proteins in FCD likely results from enhanced transcription of IF genes in dysplastic neurons and propose that future analysis of transcriptional elements that regulate IF expression be evaluated in FCD.
Similar articles
- Internexin, MAP1B, and nestin in cortical dysplasia as markers of developmental maturity.
Crino PB, Trojanowski JQ, Eberwine J. Crino PB, et al. Acta Neuropathol. 1997 Jun;93(6):619-27. doi: 10.1007/s004010050660. Acta Neuropathol. 1997. PMID: 9194902 - Expression of neural stem cell surface marker CD133 in balloon cells of human focal cortical dysplasia.
Ying Z, Gonzalez-Martinez J, Tilelli C, Bingaman W, Najm I. Ying Z, et al. Epilepsia. 2005 Nov;46(11):1716-23. doi: 10.1111/j.1528-1167.2005.00276.x. Epilepsia. 2005. PMID: 16302851 - Pathophysiologic characteristics of balloon cells in cortical dysplasia.
Oh HS, Lee MC, Kim HS, Lee JS, Lee JH, Kim MK, Woo YJ, Kim JH, Kim HI, Kim SU. Oh HS, et al. Childs Nerv Syst. 2008 Feb;24(2):175-83. doi: 10.1007/s00381-007-0453-z. Epub 2007 Sep 26. Childs Nerv Syst. 2008. PMID: 17899129 - Focal cortical dysplasia: a neuropathological and developmental perspective.
Cotter DR, Honavar M, Everall I. Cotter DR, et al. Epilepsy Res. 1999 Sep;36(2-3):155-64. doi: 10.1016/s0920-1211(99)00049-2. Epilepsy Res. 1999. PMID: 10515163 Review. - What can be learned from intermediate filament gene regulation in the mouse embryo.
Duprey P, Paulin D. Duprey P, et al. Int J Dev Biol. 1995 Jun;39(3):443-57. Int J Dev Biol. 1995. PMID: 7577435 Review.
Cited by
- Spatial patterns of the pathological changes in neuronal intermediate filament inclusion disease (NIFID): an alpha-internexin immunohistochemical study.
Armstrong RA, Cairns NJ. Armstrong RA, et al. J Neural Transm (Vienna). 2007;114(4):451-6. doi: 10.1007/s00702-006-0595-2. Epub 2006 Nov 17. J Neural Transm (Vienna). 2007. PMID: 17109074 - Utility of linearly amplified RNA for RT-PCR detection of chromosomal translocations: validation using the t(2;5)(p23;q35) NPM-ALK chromosomal translocation.
Schumacher JA, Jenson SD, Elenitoba-Johnson KS, Lim MS. Schumacher JA, et al. J Mol Diagn. 2004 Feb;6(1):16-21. doi: 10.1016/S1525-1578(10)60486-2. J Mol Diagn. 2004. PMID: 14736822 Free PMC article. - Early progenitor cell marker expression distinguishes type II from type I focal cortical dysplasias.
Orlova KA, Tsai V, Baybis M, Heuer GG, Sisodiya S, Thom M, Strauss K, Aronica E, Storm PB, Crino PB. Orlova KA, et al. J Neuropathol Exp Neurol. 2010 Aug;69(8):850-63. doi: 10.1097/NEN.0b013e3181eac1f5. J Neuropathol Exp Neurol. 2010. PMID: 20613634 Free PMC article. - Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function.
Meikle L, Pollizzi K, Egnor A, Kramvis I, Lane H, Sahin M, Kwiatkowski DJ. Meikle L, et al. J Neurosci. 2008 May 21;28(21):5422-32. doi: 10.1523/JNEUROSCI.0955-08.2008. J Neurosci. 2008. PMID: 18495876 Free PMC article. - Nestin in central nervous system cells.
Gilyarov AV. Gilyarov AV. Neurosci Behav Physiol. 2008 Feb;38(2):165-9. doi: 10.1007/s11055-008-0025-z. Neurosci Behav Physiol. 2008. PMID: 18197384 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous